mTORC1 inhibition in cancer cells protects from glutaminolysis-mediated apoptosis during nutrient limitation
Inhibitors of the mTORC1 pathway are considered anti-cancer drugs. Here, the authors show that on nutrient restriction, glutaminolysis-induced activation of mTORC1 induces apoptosis via inhibiting autophagy, highlighting that under such conditions inhibition of mTORC1 results in survival of cancer c...
Saved in:
Main Authors: | Victor H. Villar, Tra Ly Nguyen, Vanessa Delcroix, Silvia Terés, Marion Bouchecareilh, Bénédicte Salin, Clément Bodineau, Pierre Vacher, Muriel Priault, Pierre Soubeyran, Raúl V. Durán |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2017
|
Subjects: | |
Online Access: | https://doaj.org/article/10a70e280d43468aa959ed6e6598adf2 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Two parallel pathways connect glutamine metabolism and mTORC1 activity to regulate glutamoptosis
by: Clément Bodineau, et al.
Published: (2021) -
mTORC1 and mTORC2 regulate skin morphogenesis and epidermal barrier formation
by: Xiaolei Ding, et al.
Published: (2016) -
Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2.
by: Morris E Feldman, et al.
Published: (2009) -
Crosstalks between mTORC1 and mTORC2 variagate cytokine signaling to control NK maturation and effector function
by: Fangjie Wang, et al.
Published: (2018) -
Differential controls of MAIT cell effector polarization by mTORC1/mTORC2 via integrating cytokine and costimulatory signals
by: Huishan Tao, et al.
Published: (2021)